Nitro "pohl" Infus Voor Perfusorpompsystemen (Glyceryl Trinitrate)

Glyceryl Trinitrate, the active ingredient in Nitro "pohl" Infus Voor Perfusorpompsystemen, is a nitrate vasodilator presented as an intravenous infusion solution for intravenous use. It treats angina pectoris, acute heart failure and severe hypertension in patients who need rapid vasodilation.

GNH USA supplies Nitro "pohl" Infus Voor Perfusorpompsystemen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitro "pohl" Infus contains glyceryl trinitrate, a nitrate vasodilator that acts on the coronary and systemic circulation. It is employed in the following clinical situations:

Angina pectoris: provides rapid relief of chest pain by decreasing myocardial oxygen demand. Acute heart failure: improves cardiac output by reducing preload and afterload. Severe hypertension: lowers blood pressure promptly through systemic vasodilation.

Glyceryl trinitrate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: throbbing pain often occurring shortly after infusion. - Flushing: warmth and redness of the skin. - Dizziness or light‑headedness: due to lowered blood pressure. - Hypotension: mild to moderate drop in blood pressure. - Tachycardia: compensatory increase in heart rate. - Nausea: occasional gastrointestinal upset.

Serious or Rare Side Effects: - Severe hypotension: profound drop in blood pressure leading to shock. - Methemoglobinemia: impaired oxygen delivery in blood. - Myocardial infarction: rare but possible in susceptible patients. - Allergic reactions: rash, itching, or anaphylaxis. - Syncope: sudden loss of consciousness. - Cardiac arrhythmias: irregular heart rhythms.

When using Nitro "pohl" Infus, several precautions should be observed to ensure patient safety.

Monitor blood pressure: check regularly during infusion to avoid excessive hypotension. Avoid concomitant PDE5 inhibitors: co‑administration with sildenafil, tadalafil or similar agents can cause severe hypotension. Use with caution in anemia: reduced oxygen‑carrying capacity may worsen tissue hypoxia. Adjust dose in intracranial pressure: elevated pressure may be aggravated by vasodilation. Contraindicated in severe aortic stenosis: fixed outflow obstruction can lead to cardiovascular collapse. Store below 25°C: keep in original container, protect from light and moisture.

Glyceryl trinitrate can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): risk of profound hypotension. - Other nitrates or nitrovasodilators: additive blood‑pressure‑lowering effect.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance hypotensive effect. - Beta‑blockers: can mask tachycardia response to hypotension. - Diuretics or other antihypertensives: may require dose adjustment.